Similar results were obtained when a cis‐acting variant was used as the genetic instrument (ie, rs17366568 in ADIPOQ gene) (overall colorectal cancer; OR = 0.92 [95% CI = 0.82‐1.03]; P = .16) (Table S2). This evidence concerns the gene ADIPOQ and colorectal cancer.